For instance, it was shown that 3-IAld could limit graft-versus-host disease (GvHD) by activating type I IFN signaling [46], consistent with the notion that not only the diversity of the ligands, but also the context in which AhR is activated may direct downstream signaling pathways. The gene discussed is AHR; the disease is graft versus host disease.